Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey.
作者信息
Kenney James T, Gleason Patrick P
机构信息
JTKENNEY, LLC.
Prime Therapeutics, LLC.
出版信息
J Manag Care Spec Pharm. 2025 Jan;31(1-b Suppl):S20-S24. doi: 10.18553/jmcp.2025.31.1-b.s20.
Abstract
摘要
相似文献
1
Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Jan;31(1-b Suppl):S20-S24. doi: 10.18553/jmcp.2025.31.1-b.s20.
2
Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Feb;31(2-a Suppl):S20-S24. doi: 10.18553/jmcp.2025.31.2-a.s20.
3
Emerging trends in therapeutics and diagnostics: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Feb;31(2-a Suppl):S15-S19. doi: 10.18553/jmcp.2025.31.2-a.s15.
4
Emerging trends in public policy: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Feb;31(2-a Suppl):S29-S33. doi: 10.18553/jmcp.2025.31.2-a.s29.
5
Emerging trends in patient experience data: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Feb;31(2-a Suppl):S34-S37. doi: 10.18553/jmcp.2025.31.2-a.s34.
6
Emerging trends in information technology: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Feb;31(2-a Suppl):S11-S14. doi: 10.18553/jmcp.2025.31.2-a.s11.
7
Emerging trends in pharmacy operations: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Feb;31(2-a Suppl):S25-S28. doi: 10.18553/jmcp.2025.31.2-a.s25.
8
Emerging trends in patient experience data: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Jan;31(1-b Suppl):S34-S37. doi: 10.18553/jmcp.2025.31.1-b.s34.
9
Emerging trends in public policy: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Jan;31(1-b Suppl):S11-S14. doi: 10.18553/jmcp.2025.31.1-b.s11.
10
Emerging trends in pharmacy operations: Perspectives on the 2024 AMCP Foundation Survey.
J Manag Care Spec Pharm. 2025 Jan;31(1-b Suppl):S25-S28. doi: 10.18553/jmcp.2025.31.1-b.s25.
本文引用的文献
1
Emerging trends in managed care pharmacy: A mixed-method study.
J Manag Care Spec Pharm. 2025 Feb;31(2-a Suppl):S2-S10. doi: 10.18553/jmcp.2025.31.2-a.s2.
3
Pharmacy Benefit Manager Market Concentration for Prescriptions Filled at US Retail Pharmacies.
JAMA. 2024 Oct 15;332(15):1298-1299. doi: 10.1001/jama.2024.17332.
4
Affordability and adherence gains for Medicare Part D low-income subsidy recipients when low-income subsidy benefits expanded in 2024.
J Manag Care Spec Pharm. 2024 Jul;30(7):728-735. doi: 10.18553/jmcp.2024.30.7.728.
5
340B Contract pharmacy growth by pharmacy ownership: 2009-2022.
Health Aff Sch. 2023 Dec 9;2(1):qxad075. doi: 10.1093/haschl/qxad075. eCollection 2024 Jan.
6
Direct-to-Consumer Drug Company Pharmacies.
JAMA. 2024 Mar 26;331(12):1003-1004. doi: 10.1001/jama.2024.2911.
7
Outcomes of the 340B Drug Pricing Program: A Scoping Review.
JAMA Health Forum. 2023 Nov 3;4(11):e233716. doi: 10.1001/jamahealthforum.2023.3716.
8
Value-Based Pharmaceutical Contracts: Value for Whom?
Value Health. 2020 Feb;23(2):154-156. doi: 10.1016/j.jval.2019.10.009. Epub 2019 Dec 5.
9
Performance-Based Risk-Sharing Arrangements for Pharmaceutical Products in the United States: A Systematic Review.
J Manag Care Spec Pharm. 2017 Oct;23(10):1028-1040. doi: 10.18553/jmcp.2017.23.10.1028.
10
Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
J Manag Care Pharm. 2012 Nov-Dec;18(9):690-700. doi: 10.18553/jmcp.2012.18.9.690.
Zotero 插件